Weight gain during menopause frustrates countless women—but what if there was a science-backed solution that addressed the underlying hormonal shifts? Michelle Cardel, Chief Nutrition Officer at Weight Watchers, takes us on an eye-opening journey through the world of GLP-1 medications, debunking myths and revealing surprising truths along the way.

Originally developed for diabetes management, these medications have revolutionized weight management by targeting the biological drivers of hunger. "They mimic a natural hormone that helps regulate blood sugar, reduces appetite, and slows gastric emptying," explains Cardel. The result? A remarkable reduction in what researchers call "food noise"—that persistent, all-consuming focus on eating that many women experience during menopause.

Perhaps most surprising is the medication's impact beyond the scale. Weight Watchers research shows an astonishing 50% improvement in overall quality of life for GLP-1 users, affecting everything from self-esteem to sexual function. "Women report feeling more in control around food, with less urgency to snack or overeat," notes Cardell, making these medications particularly valuable during hormonal transitions.

Contrary to circulating fears, Cardel addresses bone health concerns head-on: "Research has shown GLP-1 medications might actually be beneficial for bone formation." However, she emphasizes the importance of resistance training, adequate protein, and a comprehensive approach. Her simple-to-remember 30-30-30 rule provides practical guidance: aim for 30 grams of protein per meal, 30 grams of fiber daily, and 30 minutes of physical activity.

The conversation shifts from viewing GLP-1s as a "shortcut" to recognizing them as legitimate treatment for a chronic condition. As Cardel powerfully states, "Just as we support treatment for other conditions like asthma or hypertension, using GLP-1s to support weight and metabolic health is a science-backed choice." For women navigating menopause, this perspective offers not just hope but permission to prioritize their health without shame or stigma.

Ready to transform your understanding of weight management during menopause? Listen now and discover if GLP-1 medications might be part of your midlife wellness journey.

Website: https://www.weightwatchers.com

@dr.michellecardel

Dr. Cardel is a nutrition scientist, registered dietitian, and Chief Nutrition Officer at WeightWatchers. She also serves as a faculty member at the University of Florida, where she co-directs the Center for Integrative Cardiovascular and Metabolic Diseases. At WeightWatchers, Dr. Cardel leads clinical trials, the program innovation team, and nutrition and food database. Her team shapes the organization’s nutrition strategy using the latest science, develops evidence-based programs, and the most cutting-edge science is integrated into member programs and content.

A Fellow of The Obesity Society, Dr. Cardel has authored over 125 publications in high-impact journals like JAMA, JAMA Pediatrics, AJCN, and Obesity. Her numerous accolades include the University of Alabama (UAB) Outstanding Woman Award, the Academy of Nutrition and Dietetics Excellence in Emerging Outcomes Research Award, UAB’s Young Alumni Rising Star Award, and The Obesity Society’s Practitioner of the Year Award for Excellence in Clinical Care and Management of Obesity.

MiDOViA LINKS:

Website: https://www.midovia.com/
Instagram: https://www.instagram.com/mymidovia
LinkedIn: http://www.linkedin.com/midovia
Email Us: info@midovia.com

MiDOViA is dedicated to changing the